Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Johnson and Johnson
Dow
US Department of Justice
Citi
Medtronic
Cantor Fitzgerald
McKesson

Generated: November 12, 2018

DrugPatentWatch Database Preview

Medicis Company Profile

« Back to Dashboard

What is the competitive landscape for MEDICIS, and what generic alternatives to MEDICIS drugs are available?

MEDICIS has twenty approved drugs.

There are twenty-four US patents protecting MEDICIS drugs.

Summary for Medicis
US Patents:24
Tradenames:19
Ingredients:17
NDAs:20
Patent Litigation for Medicis: See patent lawsuits for Medicis

Drugs and US Patents for Medicis

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes 9,199,977 ➤ Sign Up Y Y ➤ Sign Up
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-004 Jul 23, 2009 AB RX Yes No 7,919,483 ➤ Sign Up ➤ Sign Up
Medicis THEOLAIR theophylline TABLET;ORAL 086399-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up
Medicis Pharms PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 075250-001 Jul 12, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-004 Jul 23, 2009 AB RX Yes No 8,252,776 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Medicis

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis METROGEL-VAGINAL metronidazole GEL;VAGINAL 020208-001 Aug 17, 1992 5,536,743 ➤ Sign Up
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-005 Jul 23, 2009 5,908,838 ➤ Sign Up
Medicis MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 020014-001 Nov 30, 1992 4,664,107 ➤ Sign Up
Medicis ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 5,721,275 ➤ Sign Up
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-008 Aug 27, 2010 5,908,838 ➤ Sign Up
Medicis SOLODYN minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 050808-003 May 8, 2006 5,908,838 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for MEDICIS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 65 mg and 115 mg ➤ Subscribe 2009-11-19
➤ Subscribe Extended-release Tablet 105 rng ➤ Subscribe 2010-12-28
➤ Subscribe Cream 5% ➤ Subscribe 2006-10-17
➤ Subscribe Cream 3.75% ➤ Subscribe 2012-08-08
➤ Subscribe Gel 1.2%/0.025% ➤ Subscribe 2010-12-17
➤ Subscribe Gel 0.77% ➤ Subscribe 2006-05-10
➤ Subscribe Extended-release Tablet 55 mg and 80 mg ➤ Subscribe 2010-12-02
➤ Subscribe Cream 0.10% ➤ Subscribe 2008-01-31
➤ Subscribe Cream 2.5% ➤ Subscribe 2014-06-17
➤ Subscribe Vaginal Gel 0.75% ➤ Subscribe 2004-09-02

Supplementary Protection Certificates for Medicis Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/040 United Kingdom ➤ Sign Up PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
C/GB06/021 United Kingdom ➤ Sign Up PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201
C/GB00/021 United Kingdom ➤ Sign Up PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316
90064-1 Sweden ➤ Sign Up PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
C0021 Belgium ➤ Sign Up PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
90049-3 Sweden ➤ Sign Up PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cerilliant
Merck
Citi
Julphar
US Department of Justice
Daiichi Sankyo
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.